Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis

Methotrexate (MTX)‐associated lymphoproliferative disorder (MTX‐LPD) is a troublesome problem in patients receiving MTX for rheumatoid arthritis (RA). However, its incidence, prognosis, and risk factors remain unclear. In this retrospective study, we evaluated the actual incidence, prognostic impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Keisuke, Ichikawa, Ayako, Umezawa, Natsuka, Yamamoto, Kouhei, Yoshifuji, Kota, Okada, Keigo, Nogami, Ayako, Umezawa, Yoshihiro, Nagao, Toshikage, Sakashita, Chizuko, Mori, Takehiko, Tohda, Shuji, Koike, Ryuji, Yasuda, Shinsuke, Yamamoto, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475769/
https://www.ncbi.nlm.nih.gov/pubmed/37365854
http://dx.doi.org/10.1111/cas.15894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475769/
https://www.ncbi.nlm.nih.gov/pubmed/37365854
http://dx.doi.org/10.1111/cas.15894

Ejemplares similares